Search - tctmd.com

Displaying 801 - 820 of 926

Sort: Relevancy | Date

News Conference News AHA 2012

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

Jason Kahn

November 06, 2012

News Conference News AHA 2012

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

November 04, 2012

News Industry News

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

October 31, 2012

News Conference News TCT 2012

PARTNER: Benefits of TAVR Sustained Out to 3 Years

October 25, 2012

News Conference News TCT 2012

Experts Discuss Future of Renal Denervation

October 25, 2012

News Industry News

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

October 25, 2012

News Industry News

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

October 25, 2012

News Industry News

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

October 24, 2012

News Industry News

PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy

October 24, 2012

News Conference News TCT 2012

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

October 24, 2012

News Industry News

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

October 24, 2012

News Daily News

SCAI Survey, Consensus Statement Draw Attention to Quality of Life

Caitlin E. Cox

October 23, 2012

News Conference News TCT 2012

COURAGE, FAME: Revascularization More Effective Than OMT

October 22, 2012

News Daily News

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

October 19, 2012

News Daily News

Revascularization After CTA Confers Mortality Benefit in Stable Patients at High Risk

L.A. McKeown

October 15, 2012

News Daily News

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

October 12, 2012

News Daily News

Many Factors Contributed Toward Periprocedural Stroke in SAMMPRIS Trial

September 21, 2012

News Daily News

Renal Stenting Shows Potential for Marked BP Lowering in Uncontrolled Hypertension

L.A. McKeown

September 10, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

Advertisement

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

PARTNER: Benefits of TAVR Sustained Out to 3 Years

Experts Discuss Future of Renal Denervation

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy

Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

SCAI Survey, Consensus Statement Draw Attention to Quality of Life

COURAGE, FAME: Revascularization More Effective Than OMT

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

Revascularization After CTA Confers Mortality Benefit in Stable Patients at High Risk

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

Many Factors Contributed Toward Periprocedural Stroke in SAMMPRIS Trial

Renal Stenting Shows Potential for Marked BP Lowering in Uncontrolled Hypertension

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content